BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2025; 31(42): 111291
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111291
Could artificial intelligence-powered colonoscopies change the future of colorectal cancer screening?
Mircea Mănuc, Cătălin-Andrei Duței, Teodora-Ecaterina Mănuc, Andreea-Elena Chifulescu, Florin Andrei Grama
Mircea Mănuc, Cătălin-Andrei Duței, Teodora-Ecaterina Mănuc, Andreea-Elena Chifulescu, Department of Gastroenterology, “Carol Davila” University of Medicine and Pharmacy, Bucharest 050474, Romania
Florin Andrei Grama, Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest 050474, Romania
Co-corresponding authors: Cătălin-Andrei Duței and Teodora-Ecaterina Mănuc.
Author contributions: Duței CA and Mănuc M designed the review; Duței CA wrote the manuscript; Mănuc TE, Chifulescu AE and Grama FA selected the data and analytic tools; all authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Cătălin-Andrei Duței, MD, Doctor, Department of Gastroenterology, “Carol Davila” University of Medicine and Pharmacy, Blv. Eroii Sanitari, nr 8, Bucharest 050474, Romania. catalin-andrei.dutei@drd.umfcd.ro
Received: June 27, 2025
Revised: August 13, 2025
Accepted: October 10, 2025
Published online: November 14, 2025
Processing time: 139 Days and 17.1 Hours
Abstract

Colorectal cancer is a major cause of cancer-related mortality worldwide, underscoring the importance of early and effective colorectal cancer screening to improve survival rates. Traditional colorectal cancer screening methods include non-invasive tests, such as the fecal immunochemical test (FIT), as well as diagnostic procedures like colonoscopy. Colonoscopy remains the gold standard for detecting and treating precancerous polyps and early-stage cancer, regardless of whether it is used as the first screening test or the second test following a positive FIT. However, its effectiveness can be affected by factors such as operator skill, patient variability, and limited lesion visibility, resulting in a significant rate of missed lesion rates and highlighting the need for more efficient and accurate screening techniques. This review is aimed to assess the current challenges of traditional screening methods with the impact of artificial intelligence (AI) in the diagnostic flow. The literature on AI-powered tools for colorectal cancer screening, including novel applications, emerging programs, and recent guidelines, has been reviewed to highlight both the advantages and limitations of implementing this technology in healthcare. Recent advances in AI have introduced soft AI colonoscopy, with the purpose of improving lesion recognition (computer-aided detection) and/or improving optical diagnosis (computer-aided diagnosis). AI-powered colonoscopy systems employ deep learning algorithms to analyze real-time endoscopic images, enhancing detection rates for adenomas, serrated lesions and cancer by reducing human error. AI-assisted colonoscopy enhances adenoma detection, enabling earlier intervention and improved patient outcomes. The benefits are particularly pronounced for less-experienced practitioners, as the detection rates for AI-assisted colonoscopy are similar to experts. AI integration also helps in the teaching process, in developing standardized procedures, and improving screening procedure accuracy and efficiency across different healthcare providers. However, there are challenges and limitations, such as the cost of AI implementation, data privacy concerns, and the need for extensive clinical validation. As AI technology continues to evolve, its transformation of the colorectal cancer screening system could revolutionize the field, making early detection more accessible and reducing mortality, on the condition that the above issues are addressed before widespread use.

Keywords: Colorectal cancer screening; Colorectal cancer; Artificial intelligence; Artificial intelligence powered colonoscopy; Adenoma detection rate

Core Tip: Colorectal cancer screening has evolved considerably in recent years, with recommended procedures increasingly incorporated into clinical guidelines to enhance early detection. Advances in artificial intelligence have enabled its integration across multiple stages of screening, improving diagnostic accuracy, supporting clinician performance, enhancing imaging, and optimizing patient preparation. However, limitations remain, and artificial intelligence applications must continue to be refined and adjusted for real-world use, particularly with regard to social, privacy and financial considerations.